Browsing: Coverage

Two weeks ago, the Food and Drug Administration approved Xolair (omalizumab) for immunoglobulin E-mediated food allergy in certain adults and…

I’ve been in public relations for over 15 years, and in that time, it feels like I’ve seen and heard…